A Ambrosini


Affiliation: IRCCS Neuromed
Country: Italy


  1. request reprint
    Ambrosini A. Occipital nerve stimulation for intractable cluster headache. Lancet. 2007;369:1063-5 pubmed
  2. request reprint
    Ambrosini A, Vandenheede M, Rossi P, Aloj F, Sauli E, Pierelli F, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain. 2005;118:92-6 pubmed
    ..Remission lasted between 4 and 26 months in five patients. A single suboccipital steroid injection completely suppresses attacks in more than 80% of CH patients. This effect is maintained for at least 4 weeks in the majority of them. ..
  3. Ambrosini A, D Alessio C, Magis D, Schoenen J. Targeting pericranial nerve branches to treat migraine: Current approaches and perspectives. Cephalalgia. 2015;35:1308-22 pubmed publisher
    ..Larger, well-designed and comparative trials are needed to appraise the respective advantages, disadvantages and indications of most interventions discussed here. ..
  4. Ambrosini A, Iezzi E, Perrotta A, Kisialiou A, Nardella A, Berardelli A, et al. Correlation between habituation of visual-evoked potentials and magnetophosphene thresholds in migraine: A case-control study. Cephalalgia. 2016;36:258-64 pubmed publisher
    ..e. a punctual normal measure of the cortical activation threshold for PT and a dynamic response pattern to repeated stimuli for VEP habituation. ..
  5. request reprint
    Ambrosini A, D Onofrio M, Grieco G, Di Mambro A, Montagna G, Fortini D, et al. Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology. 2005;65:1826-8 pubmed
    ..Mutations in CACNA1A and ATP1A2 have been found in FHM. The authors detected a novel mutation in the ATP1A2 gene (R548H) in members of a family with BM, suggesting that BM and FHM may be allelic disorders. ..